SCHEMBL4756520

SCHEMBL4756520

O=C(O)NCc1ccc(-c2nc3c(N4CCN(Cc5cccnc5)CC4)c(Cl)cnc3[nH]2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 8/20 0.48
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
TRPA1 O75762 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KCNH2 Q12809 1/20 0.42
KDR P35968 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211891 0.90 AURKA (0.56) AURKAHDAC3HDAC4HDAC1HDAC7
SCHEMBL13985593 0.89 AURKA (0.45) AURKAHDAC3HDAC4HDAC1HDAC7
SCHEMBL13985474 0.87 AURKA (0.52) AURKACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL211129 0.86 AURKA (0.48) AURKAHDAC3HDAC4HDAC1HDAC7
SCHEMBL210671 0.86 AURKA (0.64) AURKACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL210907 0.84 AURKA (0.54) AURKACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL211945 0.83 AURKA (0.50) AURKACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL4757123 0.83 AURKA (0.60) AURKAKCNH2
SCHEMBL211046 0.83 AURKA (0.49) AURKAHDAC3HDAC4HDAC1HDAC7
SCHEMBL4790505 0.82 AURKA (0.54) AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001021-A1 IMIDAZOPYRIDINE DERIVATIVES USEFUL AS ENZYME INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE AND AUTOIMMUNE DISEASES CHROMA THERAPEUTICS LTD. (GB) 2008-12-31 WO disclosed